168 related articles for article (PubMed ID: 21323677)
21. Pharmacokinetics of buprenorphine hydrochloride following intramuscular and intravenous administration to American kestrels (Falco sparverius).
Gustavsen KA; Guzman DS; Knych HK; Petritz OA; Olsen GH; Paul-Murphy JR
Am J Vet Res; 2014 Aug; 75(8):711-5. PubMed ID: 25061701
[TBL] [Abstract][Full Text] [Related]
22. The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue.
Boström E; Jansson B; Hammarlund-Udenaes M; Simonsson US
Rapid Commun Mass Spectrom; 2004; 18(21):2565-76. PubMed ID: 15468158
[TBL] [Abstract][Full Text] [Related]
23. Intranasal absorption of oxymorphone.
Hussain MA; Aungst BJ
J Pharm Sci; 1997 Aug; 86(8):975-6. PubMed ID: 9269879
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of glycopyrrolate following intravenous administration in the horse.
Rumpler MJ; Sams RA; Colahan P
J Vet Pharmacol Ther; 2011 Dec; 34(6):605-8. PubMed ID: 21366622
[No Abstract] [Full Text] [Related]
26. Pharmacokinetics of intravenous and intramuscular tramadol in llamas.
Cox S; Martin-Jimenez T; van Amstel S; Doherty T
J Vet Pharmacol Ther; 2011 Jun; 34(3):259-64. PubMed ID: 21492191
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of intravenous and intramuscular buprenorphine in the horse.
Davis JL; Messenger KM; LaFevers DH; Barlow BM; Posner LP
J Vet Pharmacol Ther; 2012 Feb; 35(1):52-8. PubMed ID: 21392040
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of the antihyperglycemic agent metformin in cats.
Michels GM; Boudinot FD; Ferguson DC; Hoenig M
Am J Vet Res; 1999 Jun; 60(6):738-42. PubMed ID: 10376904
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of etomidate in cats.
Wertz EM; Benson GJ; Thurmon JC; Tranquilli WJ; Davis LE; Koritz GD
Am J Vet Res; 1990 Feb; 51(2):281-5. PubMed ID: 2301840
[TBL] [Abstract][Full Text] [Related]
30. Sedative effects and serum drug concentrations of oxymorphone and metabolites after subcutaneous administration of a liposome-encapsulated formulation in dogs.
Smith LJ; Krugner-Higby L; Trepanier LA; Flaska DE; Joers V; Heath TD
J Vet Pharmacol Ther; 2004 Oct; 27(5):369-72. PubMed ID: 15500576
[No Abstract] [Full Text] [Related]
31. Low-level quantitation of oxycodone and its oxidative metabolites, noroxycodone, and oxymorphone, in rat plasma by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
Edwards SR; Smith MT
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):264-70. PubMed ID: 17098487
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of tramadol in horses after intravenous, intramuscular and oral administration.
Shilo Y; Britzi M; Eytan B; Lifschitz T; Soback S; Steinman A
J Vet Pharmacol Ther; 2008 Feb; 31(1):60-5. PubMed ID: 18177320
[TBL] [Abstract][Full Text] [Related]
33. Letter to the editor. Use of oral oxymorphone.
Kerwin R
Consult Pharm; 2007 Dec; 22(12):972-3; author reply 973-4. PubMed ID: 18210674
[No Abstract] [Full Text] [Related]
34. Pharmacokinetics of intravenously administered caffeine in healthy alpacas (Lama pacos) and llamas (Lama glama).
Lakritz J; Middleton JR; Anderson DE; Linden DR; Sams RA; Tessman RK; Tyler JW
Am J Vet Res; 2006 Jun; 67(6):1063-9. PubMed ID: 16740103
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of butorphanol in cats after intramuscular and buccal transmucosal administration.
Wells SM; Glerum LE; Papich MG
Am J Vet Res; 2008 Dec; 69(12):1548-54. PubMed ID: 19045999
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of fentanyl administered transdermally and intravenously in sheep.
Ahern BJ; Soma LR; Rudy JA; Uboh CE; Schaer TP
Am J Vet Res; 2010 Oct; 71(10):1127-32. PubMed ID: 20919897
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of long-acting nalbuphine decanoate after intramuscular administration to Hispaniolan Amazon parrots (Amazona ventralis).
Sanchez-Migallon Guzman D; KuKanich B; Heath TD; Krugner-Higby LA; Barker SA; Brown CS; Paul-Murphy JR
Am J Vet Res; 2013 Feb; 74(2):191-5. PubMed ID: 23363341
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of nalbuphine hydrochloride after intravenous and intramuscular administration to Hispaniolan Amazon parrots (Amazona ventralis).
Keller DL; Sanchez-Migallon Guzman D; Klauer JM; KuKanich B; Barker SA; Rodríguez-Ramos Fernández J; Paul-Murphy JR
Am J Vet Res; 2011 Jun; 72(6):741-5. PubMed ID: 21627518
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs.
Guedes AG; Papich MG; Rude EP; Rider MA
J Vet Pharmacol Ther; 2008 Aug; 31(4):334-43. PubMed ID: 18638294
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of yohimbine following intravenous administration to horses.
Dimaio Knych HK; Steffey EP; Deuel JL; Shepard RA; Stanley SD
J Vet Pharmacol Ther; 2011 Feb; 34(1):58-63. PubMed ID: 21219345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
